— Item7 of 19 mY wax <q Se i @ al Lo) id @A &s

— " . uL ~
Question Id: 20701 Previous Next Full Screen Tutorial Lab Values Notes Calculator Reverse Color Text Zoom Settings

A 36-year-old woman with fistulizing perianal Crohn disease comes to the office for a follow-up

a chimeric human-mouse monoclonal antibody targeted against tumor necrosis factor-alpha.

1

2

3

4
= 15
: E appointment. Eight weeks ago, the patient began receiving intermittent injections of infliximab,
- 7

8

9

She reports improvement in fistula discharge and discomfort but has experienced fever, diffuse
joint pain, and an itchy rash 5-7 days after each of the recent treatments. The symptoms
spontaneously resolve after 2-3 days. The patient has no other medical conditions and has no
history of drug allergies. A delayed drug reaction due to formation of antibodies against foreign
drug components is suspected. Which of the following mechanisms is most likely responsible
for resolution of these drug reactions?

YA. Activation of the mononuclear phagocyte system (36%)
B. Apoptosis of tissue mast cells and eosinophils (3%)
C. Clearance of intact drug molecules by kidneys (15%)
D. Endocytosis and degradation of mast cell-bound IgE (8%)

E. Regulatory T-cell-mediated cytotoxic T-cell suppression (35%)

Block Time Elapse
Tutor

End Block
